注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Prime Medicine Inc是一家總部位於美國的生物技術公司。該公司從事多種藥物研發項目,針對肝臟、眼睛、體外造血幹細胞和神經肌肉適應症。該公司的Prime Editing科技是一種解决遺傳疾病原因的革命性科技。該公司的合作方式有助於對抗疾病,加速Prime Editing的發展,為患者提供治療。它的Prime Editing被用來修改基因調控序列。這些編輯可以在與治療相關的細胞和器官中進行,包括特化的終末分化細胞。它的Prime Editing就像一個去氧核糖核酸(DNA)文字處理器,能够在基因組中精確位置蒐索和替換基因序列,而無需在DNA中產生雙鏈斷裂。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Anastasia Khvovora | 54 | 2022 | Member of Scientific Advisory Board |
Agnieszka Czechowicz | - | 2022 | Member of Scientific Advisory Board |
David R. Liu | - | 2022 | Co-Founder & Chair of Scientific Advisory Board |
Wendy K. Chung | 54 | 2021 | Independent Director |
Robert Taylor Nelsen | 61 | 2020 | Independent Director |
Yvonne Chen | - | 2022 | Member of Scientific Advisory Board |
Keith Michael Gottesdiener | 69 | 2020 | President, CEO, Secretary & Director |
Eric N. Olson | - | - | Member of Scientific Advisory Board |
Kaye I. Foster-Cheek | 63 | 2021 | Independent Director |
Guangping Gao | - | 2022 | Member of Scientific Advisory Board |
David P. Schenkein | 66 | 2019 | Independent Director |
James Haber | - | 2022 | Member of Scientific Advisory Board |
Samuel H. Sternberg | - | 2022 | Member of Scientific Advisory Board |
Shengdar Q. Tsai | - | 2022 | Member of Scientific Advisory Board |
Jay Shendure | - | 2022 | Member of Scientific Advisory Board |
Michael A. Kelly | 66 | 2021 | Independent Director |
Muthiah Manoharan | 70 | 2022 | Member of Scientific Advisory Board |
Ben Kleinstiver | - | 2022 | Member of Scientific Advisory Board |
Thomas J. Cahill | 36 | 2021 | Independent Director |
Jeffrey D. Marrazzo | 44 | 2023 | Director |
Gerald Schwank | - | 2023 | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核